November 23, 2022
TOKYO – The Health, Labor and Welfare Ministry’s meeting of experts on Tuesday decided to give emergency approval to Xocova, an oral medicine for COVID-19 developed by Shionogi & Co.
Xocova will become the country’s first domestically produced oral medicine for COVID-19 patients.